Top Results For: wegovy

Novo Nordisk Canada is considering launching new renamed versions of its Ozempic and Wegovy drugs in a move to compete with cheaper generic versions currently on the market. Health Canada approved the company’s submission for two new medications in late December. Katherine Ward has this story and more in Health Matters for Jan. 7, 2026.

On Thursday, U.S. President Donald Trump unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular weight-loss treatments Zepbound and Wegovy. Trump added the drugs will be sold at the heavily reduced Most-Favoured-Nation price.

Novo Nordisk, the makers of weight loss drugs Ozempic and Wegovy, announced Wednesday it would begin the process of laying off about 9,000 workers in a global restructuring of the company.

Researchers at the University of Manitoba are looking at how marketing for drugs like Ozempic and Wegovy influence peoples’ views on food, hunger, and weight.

In a head-to-head battle of Zepbound vs. Wegovy, new data shows the weight-loss medication Zepbound comes out on top. The data shows Zepbound to be 50 per cent more effective.

A new study has found another benefit of GLP-1 drugs, including Ozempic and Wegovy. In addition to helping with weight loss, they lower the risk of Alzheimer’s disease and dementia for Type 2 diabetics. Health reporter Katherine Ward has the details.

Ozempic, Wegovy, Zepbound and other drugs often used for weight loss can help lower the risk of a wide range of health conditions, according to a new study. But the drugs also pose certain risks. Kyle Benning explains.

Novo Nordisk says Health Canada has approved its weight loss drug Wegovy to reduce the risk of heart attacks in some adults. Kyle Benning has the details and more in Health Matters for Nov. 27, 2024.

They Kaye Competition awards $1-million a year to innovative health-care research projects at the University of Alberta Hospital. Last year, one of the projects to receive funding was Dr. Andrea Haqq’s research into how semaglutide, prescribed under the brand names Ozempic and Wegovy, affects energy expenditure in people with Type 2 diabetes and obesity.

Wegovy weight loss benefits sustained in longest medical trial to date The makers of the popular weight loss drug Wegovy say new data from one of their longest trials to date shows the drug has sustained benefits. Health reporter Katherine Ward explains.

The makers of Ozempic say their weight-loss drug Wegovy will be available to Canadians as of Monday, May 6. Joe Scarpelli has this story and more in Health Matters for May 2, 2024.

Asthma symptoms may be more common in children with stressed parents, according to a new study. And could weight-loss drug Wegovy help reduce the risk of heart attacks and strokes? Dr. Christopher Labos joins Global’s Laura Casella to weigh in.

Dr. Iris Gorfinkel joins us to unpack the latest health updates hitting Canada. She explains the arrival of the weight loss drug “Wegovy” and what you should know about it. She also touches on the avian flu scare at U.S. dairy farms and its potential impact on Canada.

A petition calling on the provincial government to cover the cost of weight management medications such as Ozempic and Wegovy is gaining traction. Diabetes and obesity specialist Dr. Ali Zentner explains what prompted her to start the petition.

There’s a new weight-loss drug on the market. Wegovy is now available in Canada. Dr. Akshay Jain with Obseity Canada explains how the drug works.

A new study suggests there is an association between taking the active drug in Ozempic and Wegovy, and the development of condition that causes blindness. Health reporter Katherine Ward has more from doctors about the rare condition, and what people taking the drug should know.

Semaglutide medications can help patients with more than just diabetes according to new research. The SELECT trial found drugs like Ozempic and Wegovy can also improve heart health and long-term weight loss. Doctors call it a breakthrough finding as work continues to understand the full scope of the drugs’ benefits. Health Reporter Katherine Ward has...

Popular weight loss drugs such as Wegovy and Ozempic come with an increased risk of severe gastrointestinal problems, including stomach paralysis, according to a study released Thursday by the University of British Columbia. The study found such effects can occur in non-diabetic patients using the drugs specifically for weight loss.

The makers of Ozempic say their weight-loss drug Wegovy will be available to patients in Canada starting Monday. Novo Nordisk’s weekly injection is approved for weight loss among patients diagnosed with obesity. Health reporter Katherine Ward has all you need to know.